A pilot study of cognitive remediation in remitted major depressive disorder patients.
Åsa HammarMaria SemkovskaIda M H BorgenSunniva MyklebostEivind H RonoldThea SveenTorill UelandRichard PorterSheri L JohnsonPublished in: Applied neuropsychology. Adult (2020)
Major depressive disorder (MDD) is associated with working memory (WM) impairments. These deficits often persist following remission and are associated with rumination, a recognized risk factor for depression relapse. The efficacy of WM-targeted cognitive remediation as a potential relapse prevention tool has not been investigated. The present pilot study aimed to investigate the feasibility, acceptability, and cognitive benefits of a WM-targeted cognitive remediation program in remitted depression. Twenty-eight MDD participants in remission were recruited. The intervention consisted of twenty-five 30-40-minute training sessions, coupled with weekly coaching, administered over a 5-week period. Before and after the intervention, a battery of objective neuropsychological tests and self-report measures was administered. Key outcomes were WM, inhibition and rumination. Acceptability of the intervention was observed, with 83% showing high motivation, along with WM gains for all completers (n = 18, 64% of recruited participants). The cognitive remediation selectively improved targeted WM functions, as measured by objective tests. This did not translate into self-reported improvements in everyday WM or inhibition. However, all but one completer achieved at least one personal goal related to WM and 44% achieved two or, the maximum possible, three such goals. For remitters whose WM was significantly enhanced after the intervention, the cognitive remediation also decreased dysphoric-mood related rumination. The successful pilot testing of the WM-targeted intervention supports the conduct of a fully powered randomized controlled trial as a relapse prevention approach in remitted MDD.
Keyphrases
- major depressive disorder
- randomized controlled trial
- bipolar disorder
- working memory
- study protocol
- cancer therapy
- depressive symptoms
- end stage renal disease
- newly diagnosed
- sleep quality
- chronic kidney disease
- type diabetes
- clinical trial
- systematic review
- traumatic brain injury
- free survival
- peritoneal dialysis
- drug delivery
- attention deficit hyperactivity disorder
- ulcerative colitis
- drug induced